Opendata, web and dolomites

HYPER-INSIGHT SIGNED

Hypermutated tumors: insight into genome maintenance and cancer vulnerabilities provided by an extreme burden of somatic mutations

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HYPER-INSIGHT project word cloud

Explore the words cloud of the HYPER-INSIGHT project. It provides you a very rough idea of what is the project "HYPER-INSIGHT" about.

soma    dna    sequences    hyper    summary    employ    advantage    occurrence    sequencing    perform    conditional    exome    global    statistical    promises    genome    cell    relationships    endeavour    advent    tumors    underlying    hypermutation    rigorous    load    maintenance    harbouring    advancing    cancer    opportunity    defects    regional    first    scientific    essentiality    mutagenic    screens    methodologically    enabled    evolutionary    affordable    complexes    ultramutated    hundreds    human    hypermutant    draw    hypermutated    machinery    position    nucleotide    acts    thereby    healthy    sparing    megabase    thereof    extreme    mutations    biology    applies    discover    hypermutating    determinants    ones    synthetic    multitude    mutational    fuel    selectively    striking    expanding    replication    single    organization    mechanisms    backgrounds    variants    promise    quantified    deficiencies    lines    repair    realizing    indels    facet    exhibit    revealing    manifest    lethality    cells    elucidate    pronged    somatic    genomics    carcinogenesis    caused   

Project "HYPER-INSIGHT" data sheet

The following table provides information about the project.

Coordinator
FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) 

Organization address
address: CARRER BALDIRI REIXAC 10-12 PARC SCIENTIFIC DE BARCELONA
city: BARCELONA
postcode: 8028
website: www.irbbarcelona.org

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙499˙812 €
 EC max contribution 1˙499˙812 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2023-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) ES (BARCELONA) coordinator 1˙499˙812.00

Map

 Project objective

Mutations are the fuel of any evolutionary process, and this also applies to carcinogenesis. The advent of affordable DNA sequencing has enabled mutagenic processes in the human soma to be quantified genome-wide, revealing a striking occurrence of hypermutated tumors. They exhibit an extreme load of somatic changes, often harbouring hundreds of single-nucleotide variants and/or indels per megabase. The HYPER-INSIGHT project is organized into three objectives, which aim to take advantage of the unique opportunity provided by genome sequences of hypermutated and ultramutated tumors. In particular, this work planned in this project aims to further our knowledge on (i) the regional organization of the DNA replication and repair program in human cells, and the determinants thereof, (ii) the extent of selection which acts on somatic variants in various pathways or complexes and (iii) opportunities for selectively targeting DNA repair deficiencies that manifest as hypermutation. Methodologically, our work will employ a three-pronged approach. First, we will perform a multitude of rigorous statistical analyses that draw on the rich and still-expanding resources provided by cancer genomics consortia. Second, we will perform exome and genome sequencing, focusing on ultramutated tumors caused by specific defects in the DNA maintenance machinery. Third, the project involves conditional essentiality screens on cancer cell lines with hypermutant backgrounds. Their goal is to discover synthetic lethality relationships, useful for targeting hypermutating cells, while sparing healthy ones. In summary, one of the promises of cancer genome sequencing projects was to elucidate the mechanisms underlying mutational processes in the human soma, advancing our understanding of this important facet of cancer biology. We will work towards realizing this promise, thereby strengthening the EU’s position in the global scientific endeavour.

 Publications

year authors and title journal last update
List of publications.
2019 Fran Supek, Ben Lehner
Scales and mechanisms of somatic mutation rate variation across the human genome
published pages: 102647, ISSN: 1568-7864, DOI: 10.1016/j.dnarep.2019.102647
DNA Repair 81 2019-10-29
2019 Rik Lindeboom, Michiel Vermeulen, Ben Lehner, Fran Supek
The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy
published pages: , ISSN: 1061-4036, DOI: 10.1038/s41588-019-0517-5
Nature Genetics in press 2019-10-29
2019 Marina Salvadores, David Mas-Ponte, Fran Supek
Passenger mutations accurately classify human tumors
published pages: e1006953, ISSN: 1553-7358, DOI: 10.1371/journal.pcbi.1006953
PLOS Computational Biology 15/4 2019-10-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYPER-INSIGHT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HYPER-INSIGHT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More  

BECAME (2020)

Bimetallic Catalysis for Diverse Methane Functionalization

Read More  

MATCH (2020)

Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research

Read More